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The current study examined pathways from childhood maltreatment to opioid misuse in 
pregnancy. We sampled 93 pregnant women at a high-risk pregnancy clinic at a university 
medical center who were in their second trimester or beyond. 55 women were considered 
high-risk due to opioid misuse and 38 women were considered high-risk due to medical 
reasons other than drug use. Results revealed sexual abuse was significantly associated with 
opioid misuse in pregnancy, while physical abuse, emotional abuse, and neglect were not. 
Furthermore, women with histories of childhood sexual abuse reported significantly higher 
levels of perceived stress during pregnancy than women who did not report a history of 
sexual abuse. However, perceived stress did not moderate the relationship between sexual 
abuse and opioid misuse. Results suggest adequately screening pregnant women for 
childhood sexual abuse history as a part of their prenatal care may help alert medical 
providers as to which women could be at an elevated risk for opioid misuse based on their 
history of sexual abuse. Integrating trauma-informed care into normal gynecology practice 
will encourage women with histories of sexual abuse to seek out medical attention rather than 
to avoid it during their pregnancy.  
Key words: opioid misuse, pregnancy, child maltreatment, sexual abuse, stress, substance use 
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The Opioid Misuse Epidemic 
Opioid misuse is a growing epidemic in the Unites States (Gottlieb & Woodcock, 
2017), with almost 30,000 people dying from opioid overdose in 2014 alone (Rudd, Aleshire, 
Zibbell, & Matthew Gladden, 2016) compared to approximately 17,000 opioid-related deaths 
in 2010 (Statistics, 2014). Moreover, approximately 25 million people engaged in opioid use 
for nonmedical reasons between 2002 and 2011, which ultimately led to almost every state in 
the country writing legislation to combat this crisis (Dart et al., 2015). Furthermore, in a 
single year (2014-2015), deaths from opioid overdoses rose from 9.0 per 100,000 to 10.4 per 
100,000, which is indicative of an 11.4% increase nationwide (Rudd, 2016). Indeed, drug-use 
disorders accounted for the largest increase in deaths between 1990 and 2010 (Murray et al., 
2013) and opioid use disorder specifically, accounted for 61% of the deaths within this 
category in 2014 (Rudd, 2016), with more people dying from overdosing on opioids than 
dying from car accidents (Paulozzi, 2012). In response to these troubling statistics, United 
States Congress passed the Drug Addiction Treatment Act (DATA, 2000) to allow physicians 
who meet particular qualifications to treat opioid use disorders with narcotic medications in 
general medical settings, such as buprenorphine  (Zedler et al., 2016). Opioid agonist 
medication-assisted treatment (MAT), which is considered to be the most effective approach 
to treating opioid use disorder by the World Health Organization (WHO, 2009), was 
historically only available through federally regulated opioid treatment programs.  
Opioid Misuse and Pregnancy  
One setting which physicians have begun treating opioid use disorders with narcotic 
medications is in pregnancy clinics.  Indeed, the number of women misusing opioids while 
pregnant has more than quadrupled between 1999 and 2014, increasing from 1.5 per 1,000 
delivery hospitalizations to 6.5 per 1,000 delivery hospitalizations, which translates to a 
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333% increase (Haight, Ko, Tong, Bohm, & Callaghan, 2018). Moreover, in all 28 states 
which provided data for this study, rates of opioid misuse in pregnancy were increasing in 
this time period.  In the state of Tennessee specifically, where the current study was 
conducted, opioid misuse in pregnancy increased from 1.19 to 5.77 per 1000 hospital births 
between 2000 and 2009 (Patrick et al., 2015), and to 11.6 per 1000 hospital births by 2013 
(Warren, Miller, Traylor, Bauer, & Patrick, 2015).   
Opioid misuse can have devastating consequences not just for the user, but for their 
offspring as well.  The dramatic rise in opioid misuse nationally in pregnant women has led 
to a 383% increase in Neonatal Opioid Withdrawal Syndrome (NOWS) in offspring between 
2000-2012 (Ko, 2016). Between 45-94% of infants exposed to opioids during pregnancy will 
go on to develop NOWS (Minozzi, Amato, Bellisario, Ferri, & Davoli, 2013), which is a 
postnatal syndrome associated with autonomic overactivity (e.g. sensory issues), central 
nervous system irritability (e.g. tremors), and gastrointestinal tract dysfunction (e.g. feeding 
difficulties; Hudak & Tan, 2012). Infants born with NOWS are more likely to have birth 
complications including low birthweight, toxemia (Minozzi et al., 2013), respiratory 
complications (Hudak & Tan, 2012), and decreased head circumference (Towers et al., 
2019). Moreover, offspring of women who misuse opioids while pregnant have a 74 fold 
increase in sudden infant death syndrome (Fajemirokun-Odudeyi et al., 2006; Ludlow, Evans, 
& Hulse, 2004). Given the serious and sometimes fatal consequences of opioid misuse in 
pregnancy (Kaltenbach, Berghella, & Finnegan, 1998), it is imperative to seek a deeper 
understanding of what factors contribute to the risk of opioid misuse in pregnancy so that 
preventative interventions can target at-risk women before they begin using opioids.  
Psychosocial Risk Factors for Opioid Misuse in Pregnancy 
Only one study to date has examined psychosocial factors that precipitate pregnant 
women beginning to misuse opioids (Towers at al., 2019) .  The current study sought to 
3 
expand upon Towers et al. (2019), who conducted psychosocial interviews with 192 pregnant 
women with Opioid Use Disorder (OUD) to ask women what factors they believed 
precipitated their OUD.  They found that the majority of pregnant women misusing opioids 
(72%) reported a history of abuse, that was most often sexual abuse (53%), for half of whom 
began before age 13.  Physical violence was reported by 18%, while verbal abuse was 
reported by 4%.  Mental illness (e.g. depression, anxiety, or PTSD) was reported by 69-71% 
of women and family or peer opioid misuse was reported by 78%.  Chronic pain, which is 
often assumed to be the precipitating event to opioid misuse, was only reported by 10%.  The 
current study seeks to expand upon these findings of Towers et al. (2019) by examining self-
reported history of child maltreatment in pregnant women who misuse opioids and 
comparing maltreatment severity (physical abuse, emotional abuse, neglect, and sexual 
abuse) of women who have a high-risk pregnancy due to medical factors and not including 
drug misuse. Given Towers et al. (2019) found that sexual abuse was the most often cited 
adverse childhood experience for pregnant women prior to begin misusing opioids, we aimed 
to examine sexual abuse, in particular, more closely, to investigate whether perceived stress 
acts as a moderator in the relationship between sexual abuse and opioid misuse.   
Theoretical Background  
The self-medication hypothesis argues that an addict’s choice of substance is not 
arbitrary.  Rather, an individual finds a drug which meets their own psychological need to 
alleviate emotional distress (Khantzian, 1987). Thus, the hypothesis suggests that drug use 
disorders stem originally from an inability to regulate negative emotions in times of stress 
(Khantzian, 2015). Experiencing any subtype of child maltreatment is theorized to inhibit the 
development of adequate self-regulation capacities to manage stress, which subsequently 
weaves through an individuals’ pattern of experiencing emotions (Khantzian, 2015). 
Moreover, it has been theorized that drug users fail to successfully internalize parenting or 
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soothing functions, which subsequently inhibits their ability to regulate their emotions later in 
life (Wieder & Kaplan, 1969). 
Although any woman who has been maltreated (e.g. physical abuse, emotional abuse, 
and neglect) as a child may be at risk for misusing opioids to self-soothe during times of 
stress, women with sexual abuse histories who are faced with the stress of pregnancy may be 
at a particularly increased risk for misusing a drug like opioids, which create a soothing effect 
on its’ users.  As such, those with sexual abuse histories may utilize less effective coping 
strategies like drug use, during a time which reminds them of their abuse (i.e. pregnancy) 
than those without sexual abuse histories, in an effort to protect themselves from emotionally 
deteriorating in this stressful time (Callahan & Hilsenroth, 2005). From an object relations 
perspective, opioids, which decrease physiological arousal, might then provide that soothing 
presence needed to adequately cope with stress which the individual cannot find elsewhere 
(Wieder & Kaplan, 1969). Women with sexual abuse histories, who are then faced with 
stressful life events like pregnancy, which often triggers memories of sexual abuse, might 
then subsequently become addicted to the substance that helps them to bear overwhelming 
affect associated with these experiences (Khantzian et al., 2005; Khantzian, 1987; Wieder & 
Kaplan, 1969). In the current study, we expected that women who report any subtype of 
maltreatment (physical abuse, sexual abuse, neglect, emotional abuse) would be more likely 
to misuse opioids than those who do not report these maltreatment subtypes, but that sexual 
abuse would be most strongly associated with opioid misuse in pregnancy compared to the 
other subtypes. 
Empirical Literature on Child Maltreatment and Opioid Misuse  
Individuals who report child maltreatment histories are more likely than those without 
maltreatment histories to engage in misuse of opiates (Heffernan et al. 2000). Heffernan et al. 
(2000) found that sexual abuse alone accounted for 8.8% of those reporting maltreatment, 
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while sexual abuse or physical abuse accounted for 27% and physical abuse alone accounted 
for 24.1%. Opioid users, regardless of gender, were 2.7 times more likely to report a history 
of sexual/physical abuse or physical abuse alone. While these findings are significant, they 
are limited by the inclusion of only two subtypes of maltreatment: physical abuse and sexual 
abuse. Mills found that 52% of an opioid-using sample reported histories of sexual abuse 
(Mills, Lynskey, Teesson, Ross, & Darke, 2005), though their findings are limited by not 
having included a control group. The current study sought to address the limitations of 
previous studies by adding a control of non-opioid users and also investigating emotional 
abuse and neglect, particularly within a population of pregnant woman. We expected to 
replicate these findings, such that opioid-misusing women would report significantly more 
child maltreatment in all subtypes than the control group. Though neglect has not yet been 
studied in a population of opioid-misusing pregnant women, previous research in general 
opioid-misuse groups have found high rates of both emotional and physical neglect (Conroy, 
Degenhardt, Mattick, & Nelson, 2009), so we expected to have similar findings in this regard.  
In the current study, we therefore expected to find that pregnant women misusing opioids 
would report more child maltreatment than pregnant women who are not misusing opioids in 
each maltreatment subtype (physical abuse, sexual abuse, neglect, emotional abuse).  
Gender Differences for Child Maltreatment History Reported by Opioid Users  
While child maltreatment is a risk factor for opioid misuse in both men and women, 
research has found gender differences with regard to maltreatment subtype associated with 
opioid misuse. Men who misuse opioids report higher rates of physical and emotional abuse, 
while women who misuse opioids report higher rates and severity of sexual abuse (Conroy et 
al., 2009). Such findings highlight sexual abuse as a particular risk factor for opioid misuse 
among women. In that sample, 72% of opioid users were female while only 36% of opioid 
users were male (Conroy et al., 2009). Findings from Conroy et al. (2009) are limited by their 
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control group, which also had a history of opioid misuse, though they had not sought 
treatment for such use. The current study sought to address these limitations by utilizing a 
control group which reports no opioid use, past or present.  
Indeed, women with histories of sexual abuse are more likely to report psychological 
reasons for why they began using drugs than women without sexual abuse histories 
(Bartholomew, Courtney, Rowan-Szal, & Simpson, 2005; Bartholomew, Rowan-Szal, 
Chatham, Nucatola, & Simpson, 2002). Furthermore, women with trauma histories have a 
higher risk for opioid misuse then men with trauma histories (Meier et al., 2014). Given that 
approximately 21,000 women between the ages of 15 and 44 misuse opioids while pregnant 
each month in the United States alone (Smith & Lipari, 2017), it is particularly important to 
understand underlying pathways from sexual abuse to opioid use in this population to reduce 
the devastating consequences opioid use can have on developing fetuses. While we expected 
to find more physical abuse, sexual abuse, neglect, and emotional abuse in women who are 
misusing opioids while pregnant, we expected that sexual abuse would be most strongly 
associated with opioid misuse compared to the other subtypes.  
Empirical Literature on the Developmental Consequences of Child Maltreatment   
McLaughlin, Sheridan, & Lambert (2014) propose different subtypes of maltreatment 
(i.e. sexual abuse versus neglect versus physical abuse) may lead to distinct outcomes.  For 
instance, they theorize that abuse interferes most with emotional and social processing, while 
neglect seems to most disrupt cognitive development. Out of all forms of child maltreatment, 
sexual abuse has been found to be the most highly associated with low mental well-being in 
adulthood (Hughes, Lowey, Quigg, & Bellis, 2016) and the most costly medical care (Walker 
et al., 1999). With this in mind, we planned to investigate the unique sequalae of sexual abuse 
as it relates to the development of opioid use in pregnant women specifically.  Moreover, 
given the severity of psychosocial outcomes of sexual abuse has been associated with the 
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severity of the abuse (Bagley & Ramsay, 1986), we plan to investigate how severity relates to 
opioid use in pregnancy in the current study. Measuring maltreatment in two ways 
(presence/absence and severity) allowed us to gain a deeper understanding of the differential 
consequences of child maltreatment with regard to opioid misuse in pregnancy and the extent 
to which the nature of the abuse or neglect impacts the likelihood of opioid misuse in 
pregnancy.  
Empirical Literature on the Relationship between Sexual Abuse and Stress 
Research consistently suggests that sexual abuse increases one’s sensitivity to stress 
later in life (Kendall-Tackett, 2002; King, Mandansky, King, Fletcher, & Brewer, 2001) 
through dysregulation of both the hypothalamic-pituitary-adrenal axis and the endogenous 
opioid system (Charney, Deutch, Krystal, Southwick, & Davis, 1993; Cohen, Pickar, & 
Dubois, 1983; Davis & Siegel, 2000; Kosten & Krystal, 1988; Van der Kolk, McFarlane, & 
Weisæth, 2012). Dysregulation of the hypothalamic-pituitary-adrenal axis results in the 
production of abnormally high or low cortisol (Altemus, Cloitre, & Dhabhar, 2003; Heim & 
Nemeroff, 2002) which subsequently impairs the stress response throughout life (McEwen, 
2000; Sanchez, Ladd, & Plotsky, 2001), potentially putting these individuals at a higher risk 
for heightened emotional reactions to stress. Indeed, individuals with histories of sexual 
abuse experience significantly higher rates of stress-related diseases (Felitti et al., 2019; Stein 
& Barrett-Connor, 2000; Walker, Katon, Roy-Byrne, Jemelka, & Russo, 1993).  
However, not all women who experience sexual abuse go on to develop difficulties 
regulating stress (Draucker, 1995; Folger et al., 2017; Harvey, 1996; Neiman, 1988; Romans, 
Martin, Anderson, O’Shea, & Mullen, 1995):  21% to 49% of children who experience sexual 
abuse do not develop any symptoms (Kendall-Tackett, Williams, & Finkelhor, 1993; 
McLeer, Deblinger, Henry, & Orvaschel, 1992) and 22% of adult survivors of sexual abuse 
exhibit no symptoms (Russell & Russell, 1986).  It is therefore possible that women with 
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histories of sexual abuse, who go on to develop a heightened stress response, may 
subsequently experience greater levels of perceived stress in pregnancy when traumatic 
memories of their abuse is triggered, and thus be at an increased risk for opioid misuse to 
manage that stress. In the current study, we therefore expected to find that perceived stress 
will moderate the relationship between sexual abuse and opioid misuse in pregnancy.  
Empirical Literature on Sexual Abuse, Perceived Stress, and Pregnancy  
Because pregnancy is naturally a stressful life event for most women (Geller, 2004), 
particularly for those with sexual abuse histories (Leeners, Richter-Appelt, Imthurn, & Rath, 
2006) and for those with high-risk pregnancies (Wang et al., 2019), we sought to investigate 
sexual abuse, specifically, more closely. Indeed, women with sexual abuse histories 
experience significantly more difficult pregnancies than those without sexual abuse histories, 
including increased discomfort and health complaints, higher nonscheduled contact with their 
medical provider, and a higher number of ultrasound examinations (Littleton, 2015; Lukasse, 
Schei, Vangen, & Øian, 2009). Women with histories of childhood sexual abuse do indeed 
report increased levels of stress during pregnancy, with many stages of pregnancy, prenatal 
care, and delivery being complicated by memories of sexual abuse (Jacobs, 1992). Indeed, 
pregnancy has been theorized to function as a re-traumatization of sexual abuse which 
occurred in childhood (Lev-Wiesel, Daphna-Tekoah, & Hallak, 2009). The current study 
sought to fill this gap in the literature by examining whether pregnant women with sexual 
abuse histories report more perceived stress and examining whether perceived stress may 
play a role in the potential relationship between sexual abuse and opioid misuse in pregnancy. 
We expected that perceived stress would moderate the relationship between child sexual 
abuse and opioid misuse in pregnancy.  
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Empirical Literature on the Relationship between Perceived Stress and Opioid Misuse 
Past research suggests a relationship between the endogenous opiate system and the 
experience of trauma (Cohen et al., 1983). Opioids inhibit the locus coeruleus, which has 
been implicated in stress reaction (Kosten & Krystal, 1988). Indeed, researchers have 
subsequently theorized that opioid users, in particular, may utilize opioids as a means of self-
medication due to the analgesic properties of opioids which can ease symptoms of 
hyperarousal associated with the experience of stress (Bremner et al., 1994; Charney et al., 
1993; Kosten & Krystal, 1998). Indeed, past research proposes that opioids may numb 
intense emotional pain, which would normally disorganize an individual with a limited ability 
to self-regulate (Blatt, Rounsaville, Eyre, & Wilber, 1984; Khantzian, Mack, & Schatzberg, 
1974; Kosten & Krystal, 1988). Previous research has also found gender differences in opioid 
use, such that the risk for co-occurring PTSD symptoms and opioid misuse were 
approximately 3 times greater for women versus men (Meier et al., 2014). Thus, it is possible 
that child maltreatment and perceived stress interact to produce an increased risk for opioid 
use in women.  
Empirical Literature on Sexual abuse, Pregnancy, and Opioid Use  
There has been only one study to date investigating the relationship between sexual 
abuse and opioid misuse in pregnancy (Towers et al., 2019). While they found strikingly high 
rates of childhood adversity, particularly with regard to sexual abuse, their findings are also 
limited by a lack of control group and by an interview method that did not cover all subtypes 
and dimensions of maltreatment. In the current study, we sought to build on these findings by 
utilizing a larger sample size and implementing a quantitative design, which includes a 
control group of women without opioid misuse who also have high-risk pregnancies, and a 
valid questionnaire about childhood maltreatment. Given both studies found sexual abuse to 
be most prevalent in their samples of opioid-misusing pregnant women, we expected that 
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sexual abuse would be most strongly associated with opioid use in pregnancy compared to 
the other maltreatment subtypes.  
Hypotheses  
1. (a) There will be significantly more child maltreatment (presence/absence; sexual
abuse, physical abuse, emotional abuse, neglect) observed in the opioid group than the
non-opioid group and (b) there will be significantly more child maltreatment
(severity; sexual abuse, physical abuse, emotional abuse, neglect) observed in the
opioid group than the non-opioid group.
2. (a) Presence of sexual abuse will be most strongly associated with opioid misuse in
pregnancy compared to the other maltreatment subtypes (presence/absence of
physical abuse, emotional abuse, emotional neglect, physical neglect) and (b) Severity
of sexual abuse, duration of sexual abuse, and age of the onset of sexual abuse will be
associated with opioid misuse in pregnancy, such that women who experienced more
severe, longer-lasting and earlier onset sexual abuse will be more likely to misuse
opioids in pregnancy than women who experienced less severe, shorter duration, or
later age onset of sexual abuse.
3. (a) Women who report histories of sexual abuse (presence/absence) will report higher
levels of perceived stress than women who do not report histories of sexual abuse and
(b) women who report more severe sexual abuse (severity) will report higher levels of
perceived stress than women who report less severe sexual abuse. 
4. The effects of sexual abuse (severity) on opioid misuse (presence/absence) will be
moderated by perceived stress, such that women who report experiencing sexual
abuse and high levels of perceived stress will be more likely to misuse opioids in
pregnancy than women who report experiencing sexual abuse but did not experience





High-Risk Pregnancy Appointment. Participants were recruited from a High-Risk 
Pregnancy Clinic at a University Medical Center in the Southeastern United States, which 
sees patients from both urban and rural areas. Any pregnant woman being seen at the clinic 
was eligible to participate in the study if they were over the age of 18 years old and were at 
least in their second trimester of their pregnancy. Women were asked by the receptionist at 
check-in whether they would be interested in participating in a 30-minute study on high-risk 
pregnancy. If they expressed interest in participating in the study, they were escorted by a 
nurse to a private examination room to meet with a research assistant. At this time, the 
research assistant explained the purpose of the study, what would be required of the 
participant, answered any questions the participant had, and obtained informed consent,  
Consent included willingness to participate in the study, complete questionnaires and to allow 
the research assistants access to their medical charts for additional information (i.e. urinalysis 
results, demographics etc.). They received a $25 gift certificate to Walmart as compensation 
for the time required to take part in the study.  
Participants  
Ninety-three women participated in the current study. Fifty-five women were high-
risk due to opioid misuse disorder and thirty-eight were high risk due to medical factors (not 
drug use), such as multiples in pregnancy, morbid obesity (body mass index > 50), 
cardiovascular, cardiopulmonary, or rheumatologic diseases. Women were initially referred 
to the high-risk pregnancy clinic by their primary care physicians. Women in both groups 
were seen at the high-risk pregnancy clinic approximately monthly until 28 weeks gestation, 
biweekly until 36 weeks gestation, and weekly from 36 weeks gestation until delivery.  
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Demographics.  Demographic information was obtained from participants’ medical records. 
See Table 1.  
Measures  
Maltreatment.  Child maltreatment subtypes and dimensions were measured with the 
Maltreatment and Abuse Chronology of Exposure (MACE; Teicher & Parigger, 2015), which 
is 52-item questionnaire that assesses child maltreatment severity along continuous scales 
which provide information regarding when and for how long an individual experienced 
maltreatment and how severe the maltreatment was. Subscales for each maltreatment subtype 
were made up of yes/no questions. The subtypes of maltreatment used in the current study are 
sexual abuse, physical abuse, emotional abuse and neglect. Severity of each subtype is 
calculated either by the total number of items endorsed, which is recalibrated to a total 
severity level between 0-10 (if there were at least five) or were rescored based on linear 
interpolation of items endorsed (if there were less than five). The MACE has been validated 
using other measures of childhood trauma (Child Trauma Questionnaire, CTQ; Bernstein et 
al., 1994), Adverse Childhood Experiences, (ACE; Dube et al., 2003) and accounted for more 
variance in psychiatric symptoms than did the ACE or CTQ. The MACE was developed 
using item response theory and provides excellent reliability utilizing the Andersen’s 
Likelihoood ratio test (Teicher & Parigger, 2015). In the current study, we used 
presence/absence of each maltreatment subtype and severity of sexual abuse (7 items), 
physical abuse (6 items), emotional abuse (10 items), emotional neglect (5 items) physical 
neglect (5 items). In addition to a continuous severity rating, we also plan to assess 
presence/absence with a categorical variable. Presence of a maltreatment subtype will be 
coded (1) if the participant endorses any of the items pertaining to this subtype, regardless of 
severity.  
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Opioid Use. Participants were assigned to the opioid group based on medical records 
of urine-based assays conducted by their medical provider at their medical appointments. 
Specifically, we utilized a dichotomous variable (yes/no) based on the participants’ urine 
sample taken within 30 days prior to taking part in the study. Women will be assigned to the 
opioid group if either prescribed (e.g., methadone or buprenorphine) or non-prescribed 
opioids are detected. Each participant had at least one urine sample within 30 days prior to 
participating in the study. For the purposes of the current study, we were specifically 
interested in examining opioid use. For this reason, women who tested positive for drugs 
other than opioids (e.g. marijuana, alcohol, cocaine, or stimulants) were excluded from our 
sample if they were not also misusing opioids. In the current sample, there are 55 participants 
in the opioid group and 38 participants in the comparison group.  
Perceived Stress. Perceived stress was measured through the stress subscale of the 
Depression, Anxiety, and Stress Scale (DASS-21; Lovibond & Lovibond, 1995), which 
consists of 21 items derived from the original 42-item DASS long-form. The stress subscale 
seeks to measure overall emotional response to stressors. Items seek to examine levels of 
irritability, agitation, impatience, and general tension. The DASS asks individuals to indicate 
the extent to which they experience these feelings on a 4-point scale, which range from 0, 
indicating the statement does not apply to them at all, to 3, indicating the statement applies to 
them “very much or most of the time.” The score for the stress subscale is obtained by 
totaling all items in the scale and multiplying the total sum by two (to double it), which 
matches the scoring for the long form of the DASS-42 (Lovibond & Lovibond, 1995). A 
higher score indicates a higher level of perceived stress. The DASS-21 has been 
demonstrated to have adequate internal consistency and convergent validity across various 
populations (Antony, Bieling, Cox, Enns, & Swinson, 1998; Clara, Cox, & Enns, 2001). In 





Preliminary analyses revealed differences between groups on age and minority ethnic 
background, such that women who used opioids during pregnancy were more likely to be 
older and less likely to be from an ethnic minority background than those in the comparison 
group. Age and ethnic minority background was controlled for in the analyses. See Table 1 
for group differences on demographic variables.   
To test our hypothesis 1(a), we conducted 5 logistic regressions to determine if  
child maltreatment (sexual abuse, physical abuse, emotional abuse, and neglect) would be 
associated with more opioid misuse in pregnancy. The categorical variable of child 
maltreatment (presence/absence) served as the independent variable and opioid misuse served 
as the dependent variable. Age and ethnic minority background were entered in step 1. Child 
maltreatment subtype (i.e. sexual abuse, physical abuse, emotional abuse, neglect) was 
entered in step 2.  
Logistic regression analyses revealed presence of maternal sexual abuse was 
significantly associated with opioid misuse in pregnancy (p < .05). However, maternal 
physical abuse, emotional abuse, and neglect were not significantly associated with opioid 
misuse in pregnancy. See Table 2.  
To test our hypothesis 1(b), that the severity of child maltreatment (sexual abuse, 
physical abuse, emotional abuse, and neglect) would be associated with more opioid misuse 
in pregnancy, we conducted 5 binary logistic regressions. The severity variable of child 
maltreatment (severity rating) served as the independent variable and opioid misuse served as 
the dependent variable. Age and ethnic minority background were entered in step 1. Child 
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maltreatment subtype (i.e. sexual abuse, physical abuse, emotional abuse, neglect) was 
entered in step 2.  
Logistic regression analyses revealed severity of maternal sexual abuse as marginally 
significant in be associated with opioid misuse in pregnancy (p = .06). However, maternal 
physical abuse, emotional abuse, and neglect were not significantly associated with opioid 
misuse in pregnancy. See Table 3. 
To test hypothesis 2(a), that the presence of sexual abuse would be most strongly 
associated with opioid misuse in pregnancy compared to the presence of other maltreatment 
subtypes (physical abuse, emotional abuse, and neglect), we conducted a binary logistic 
regression. Presence/absence of sexual abuse served as the independent variable and opioid 
misuse in pregnancy served as the dependent variable. Presence/absence of age, ethnic 
minority background, physical abuse, emotional abuse, and neglect were entered in step 1. 
Presence/absence of sexual abuse was entered in step 2. Logistic regression analyses revealed 
presence of sexual abuse was most strongly associated with opioid misuse compared to the 
presence of physical abuse, emotional abuse, and neglect (p < .05). See Table 4.  
To test hypothesis 2(b), that severity of sexual abuse would be most strongly 
associated with opioid misuse in pregnancy compared to the severity of other maltreatment 
subtypes, we conducted a binary logistic regression. Sexual abuse severity served as the 
independent variable and opioid misuse in pregnancy served as the dependent variable. Age, 
ethnic minority background, and severity of physical abuse, emotional abuse, and neglect 
were entered in step 1. Presence/absence of sexual abuse was entered into step 2. Logistic 
regression analyses revealed severity of sexual abuse was most strongly associated with 
opioid misuse compared to the severity of physical abuse, emotional abuse, and neglect  
( p = .07). See Table 5.  
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To test hypothesis 3, that women who report histories of sexual abuse 
(presence/absence) would report higher levels of perceived stress than women who do not 
report histories of sexual abuse, we conducted an ANOVA. Sexual abuse (absence/presence) 
served as the independent variable and perceived stress served as the dependent variable. Age 
and ethnic minority status were entered as covariates. Analyses revealed maternal sexual 
abuse was significantly associated with maternal perceived stress F (1, 93) = 3.29, p < .05.  
To test hypothesis 4, that the effects of sexual abuse (presence/absence) on opioid 
misuse would be moderated by perceived stress, we conducted a binary logistic regression. 
Sexual abuse and stress served as the independent variables. Opioid misuse served as the 
dependent variable. For step 1, we entered age, ethnic minority background, sexual abuse and 
stress as the covariates. For step 2, we entered the interaction term, which was 
presence/absence of sexual abuse X stress. Analyses revealed maternal perceived stress did 




Summary of Findings 
The current study is the first to find that women with histories of childhood sexual 
abuse are more likely to misuse opioids than women without such histories. We specifically 
found that the presence of sexual abuse was significantly associated with opioid misuse in 
pregnancy, while presence of physical abuse, emotional abuse, and neglect was not. 
Furthermore, we also found that the severity of sexual abuse was marginally significantly 
associated with opioid misuse in pregnancy, while physical abuse, emotional abuse, and 
neglect severity were not. Moreover, the presence of sexual abuse was significantly 
associated with opioid misuse above and beyond presence of the other maltreatment 
subtypes. Additionally, the severity of sexual abuse was marginally significantly associated 
with opioid misuse above and beyond severity of other maltreatment subtypes. Lastly, 
women who reported sexual abuse histories also reported higher levels of perceived stress 
than women who did not report such histories, but perceived stress did not moderate the 
relationship between sexual abuse and opioid misuse.  
Sexual Abuse and Opioid Misuse 
Our finding that sexual abuse was associated with opioid misuse in pregnancy is 
consistent with findings from Towers et al. (2019) who found that opioid-misusing pregnant 
women reported histories of sexual abuse more often than any other kind of child 
maltreatment. Furthermore, our study built upon these findings by adding a high-risk control 
group and an empirically-supported measure of maltreatment rather than depending on 
interview methodology. However, our findings did not support previous research which 
found that opioid users were more likely to report a history of physical abuse than non-opioid 
users (Heffernan et al., 2000). In the current sample, only sexual abuse was associated with 
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opioid misuse in pregnancy. Physical abuse, emotional abuse, and neglect were not. It is 
important to note that Heffernan et al. (2000) examined both men and women in their sample. 
Previous research has found gender differences such that men who misuse opioids report 
elevated rates of physical and emotional abuse, while women who misuse opioids report 
elevated rates of sexual abuse (Conroy et al., 2009). Such gender differences might explain 
why our results differ from Heffernan et al. (2000), but are consistent with previous research 
specifically on pregnant women.  
Sexual Abuse, Perceived Stress, and Opioid Misuse 
Contrary to our hypothesis, perceived stress did not moderate the relationship 
between sexual abuse and opioid misuse. Our findings suggest that sexual abuse was 
associated with opioid misuse but that the likelihood of subsequent opioid misuse following 
sexual abuse does not differ based on level of perceived stress reported during pregnancy. 
Moreover, experiencing sexual abuse alone, regardless of a woman’s level of perceived 
stress, significantly increased the likelihood of opioid misuse. Such findings support the need 
to identify patients with sexual abuse history before they become pregnant to avoid the 
development of opioid misuse. One way to identify these patients would be through 
screening for Adverse Childhood Experiences (ACEs) in medical visits. Identifying patients 
with histories of adverse childhood experiences as children that include sexual abuse would 
increase access to preventative treatment for these patients before they become mothers 
themselves. 
Screening for (ACEs) in Pediatrician Visits  
One way to do this would be to screen for sexual abuse in Primary Care visits in 
childhood. Despite a strong link between adverse childhood experiences and long-lasting 
health problems in adulthood (Hughes, Lowey, Quigg, & Bellis, 2016), this is not standard 
practice. Indeed, only 4% of pediatricians report asking about all adverse childhood 
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experiences and 32% report not asking about any adverse childhood experiences. For those 
who do report asking about ACEs, they generally only ask about family history of mental 
illness and whether a child’s parents have divorced or separated (Kerker et al., 2016). The 
majority of physicians do not ask about sexual abuse, physical abuse, or neglect.  
One reason medical providers may not ask about ACEs during their visits is lack of 
familiarity with ACEs and their impact on physical health. Kerker et al. (2016) found that 
only 2% of pediatricians reported being “very familiar” with the ACEs study and 76% of 
pediatrics reported that they were not at all familiar with the study. Furthermore, 79% of 
physicians felt that asking about socio-emotional stressors within a family were outside the 
scope of their job. This is particularly troubling given the strong bidirectional relationship 
with psychological and physical health (Dube et al., 2003). While most pediatricians report 
feeling as though inquiring about ACEs is outside their scope of practice, research has found 
parents strongly support pediatricians screening for ACEs during their primary care visits 
(Conn et al., 2018). With this in mind, it is also possible that pediatricians realize that should 
a child answer “yes” to questions regarding ongoing trauma, they would need to contact 
Child Protective Services, which could create a rupture in the trusting relationship between 
parent and provider. Furthermore, pediatricians may worry their involvement with DCS could 
then cause a parent to stop seeking medical care for their child.  
Screening for ACEs in Adult Primary Care Visits  
While screening for intimate partner violence is much more common place (Women, 
Yawn, Yawn, & Uden, 1992), screening for child maltreatment histories among adult 
primary care patients is also quite uncommon. Despite 20-50% of adult patients reporting 
history of child sexual, physical, or emotional abuse, 25% of adult primary care providers 
report they rarely or never screen adult patients for child maltreatment history (Weinreb et 
al., 2010). Moreover, adult primary care physicians report similar feelings regarding 
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screening for ACEs as do pediatricians; one study found that approximately two-thirds of 
adult primary care physicians did not believe that they should routinely screen for childhood 
sexual abuse. Less than one third of primary care physicians report screening female patients 
for child maltreatment and about one in eight physicians report screening male patients for 
child maltreatment. Such beliefs subsequently impact the rate of those who do screen for such 
histories (Richardson et al., 2001). Indeed, Richardson et al. (2001) found that only one in 
one hundred physicians screened for such a history. Of note, mandatory reporting laws are 
quite different for adults reporting pervious histories of trauma. If providers began regularly 
inquiring about ACEs among patients, they could begin to make psychotherapy referrals so 
these patients, child and adult, could receive adequate treatment. Doing so would likely 
improve their physical health as well.  
Screening for ACEs in Gynecologist Visits  
We know that sexual abuse also predicts health outcomes specific to pregnant women, 
such as obstetric problems, challenges with breastfeeding, and adverse outcomes for their 
infants (Leeners, Richter-Appelt, Imthurn, & Rath, 2006). Moreover, women with sexual 
abuse histories are more likely to avoid certain routine gynecological procedures, even 
outside of exams related to pregnancy, such as Pap smears and mammograms (Farley, 
Golding, & Minkoff, 2002). Screening pregnant women for childhood sexual abuse history as 
a part of their prenatal care may help alert medical providers as to which women could be at 
an elevated risk for opioid misuse based on their history of sexual abuse. Furthermore, 
screenings may also allow gynecologists to provide emotional support, psychoeducation, and 
referrals for psychotherapy, thus decreasing the risk of opioid misuse in pregnancy 
(American Academy of Pediatrics, 2014). Moreover, knowledge of sexual abuse history may 
also enable gynecologists to practice more trauma-informed care. For instance, providing a 
patient a sense of safety and control by requesting permission to touch a patient and allowing 
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them to stop the procedure when they feel uncomfortable can minimize the risk of 
retraumatizing a patient with such a history (Havig, 2008). Implementing these practices in 
medical disciplines beyond gynecology, where patients with sexual abuse histories are likely 
to feel the most anxiety, would likely improve the encourage these patients to seek regular 
medical care, provide them more pathways to access proper psychotherapy treatment, and 
improve provider-patient relationships and related outcomes.  
Implications for Patient Care 
Gynecologists can then draw associations between current difficulty with medical 
care which may bring up memories of past sexual abuse (McKegney, 1993). Doing so may 
encourage patients with histories of sexual abuse to seek out medical attention rather than to 
avoid it. Indeed, psychological insight regarding behavioral symptoms underlies many of the 
major types of empirically-supported psychotherapy (Connolly Gibbons, Crits-Christoph, 
Barber, & Schamberger, 2007). Such insight would likely be useful for both the patient and 
the physician. Indeed, reflective functioning, the ability to interpret underlying emotional 
states, has been found to mediate the relationship between childhood sexual abuse and opioid 
misuse severity in pregnancy (Macfie et al., 2020). Havig (2008) notes that trauma survivors 
may be labeled as “difficult” by providers when their trauma history interrupts the patient-
provider relationship. Such labels, and resulting attitudes from providers, may subsequently 
lead to the patient feeling revictimized and stigmatized once again (Roberts, 1996). As a 
result, feelings of victimization may then lead the patient to avoid medical care all together or 
to resort to substances to numb the psychological pain.  
Empirical Literature on Perceived Stress, Income, and Opioid Misuse 
Our findings must be conceptualized within the broader context of how opioid 
addiction became the devastating epidemic that it is today. Prior to the 1990s, opioid 
prescription for pain was not widespread. Relatedly, nor was opioid use for psychological 
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pain. Around this time, researchers began to argue that opioids could be utilized more long-
term, citing their addictive potential to be quite low (Portenoy & Foley, 1986; Zenz et al., 
1992). The pharmaceutical industry was then able to promote opioid prescription to medical 
providers unfamiliar with the addictive potential of such drugs. Indeed, it has been theorized 
that in a society exhibiting a marked intolerance of both physical pain, and emotional pain, 
the profits of opioid prescription may have outweighed the risk of addiction, and death 
(deShazo, Johnson, Eriator, & Rodenmeyer, 2018). As Sir Angus Deaton noted in his 
testimony on the economic aspects of the opioid crisis to the United States Congress, “Selling 
heroin is profitable and illegal. Selling prescription drugs is profitable and legal” (Deaton, 
2017). Providers began to prescribe opioids more and more frequently (Zhou et al., 2016) and 
ultimately the American Pain Society and the American Academy of Pain Medicine stated 
their support for opioid use as a treatment for chronic pain (Haddox et al., 1997). 
Subsequently, we saw a significant increase in opioid use, with approximately 25 million 
Americans misusing the drug between 2002 and 2011 (SAMHSA, 2012).  
Such an increase disproportionally impacted the Appalachian region of the United 
States, where there are significant differences in employment, education, and socio-economic 
status compared to the rest of the country. Moreover, recent data suggest the higher mortality 
rate found among Appalachia, where the current study was conducted, is in large part due to 
“diseases of despair,” such as alcohol abuse, illicit drug use, prescription drug use, and 
suicide which correspond with such disparities (Meit, Heffernan, Tanebaum,  Hoffmann, 
2017).  
Socio-Economic Status and Opioid Use 
While physicians have begun prescribing opioids less often in general (IQVIA, 2018), 
opioids are prescribed more often to patients who come from low socioeconomic 
backgrounds than to patients who come from more economically advantaged backgrounds 
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(Grol-Prokopczyk, 2019). While a significant portion of opioid use is illicit, increased 
prescriptions increase the amount of opioids sold illegally, particularly in economically 
disadvantaged communities. Given we know that childhood maltreatment and poverty are 
strongly associated (Kim & Drake, 2018) and that poverty is related to stress (Marmot &  
Wilkinson, 2005), those who are at the greatest risk for opioid misuse may be the very 
patients which medical providers are most likely to prescribe opioids to. While there are 
many alternatives to opioid prescription (White, 2017), more socioeconomically 
disadvantaged patients may not have adequate health insurance to cover such treatments 
(Grol-Prokopczyk, 2019). As such, medical providers may be more likely to prescribe 
opioids to low-income populations which could not afford out-of-pocket costs for alternative 
treatment methods. In the current sample, all participants received Medicare. Future research 
should examine how frequency and severity of opioid misuse during pregnancy differs based 
on socio-economic status. Furthermore, it is possible that financial stability is associated with 
other protective factors which promote resilience among childhood sexual abuse victims. 
With this in mind, it is possible that poverty could partially mediate the relationship between 
childhood sexual abuse and opioid misuse in pregnancy.  
Strengths and Limitations 
This is the first study to utilize a control group of any kind to compare child 
maltreatment histories of opioid misusing and non-opioid misusing pregnant women. We 
built upon the findings of Towers et al. (2019) by using an empirically validated measure of 
maltreatment rather an unstructured interview to gather maltreatment data. Moreover, our use 
of both categorical and continuous measures of maltreatment allowed us to consider the 
impact of the severity of such maltreatment on opioid misuse in pregnancy. Examining 
maltreatment in this way enabled us to further understand whether it is merely the presence of 
the maltreatment which puts women at a greater risk of opioid misuse or if the severity of the 
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maltreatment is what puts women at a greater risk. Indeed, severity of psychosocial outcomes 
of sexual abuse has been associated with the severity of the abuse (Bagley & Ramsay, 1986).  
One limitation of  the current study was that we did not consider age of onset of 
sexual abuse, which has also been associated with severity of psychosocial outcome (Bagley 
& Ramsay, 1986; Sedney & Brooks, 1984; Sirles, Smith, & Kusama, 1989). Future research 
should aim to examine if the age at which sexual abuse begins relates to the likelihood of 
opioid misuse occurring in pregnancy. We also only gathered retrospective data, so it is 
possible not all sexual abuse was reported. Indeed, research has found that not all sexual 
abuse is remembered  (Brown, Schelfin, & Whitfield, 1999). We also did not consider the 
severity of the opioid misuse, which could be related to sexual abuse severity as well. Future 
research should also consider frequency and quantity of opioid consumption as it relates to 
childhood sexual abuse. Furthermore, we did not gather data regarding whether these women 
were first time mothers. It is possible that women who had previously had a pregnancy would 
exhibit lower, or higher levels of stress as a result.  
Moreover, all participants in our sample were considered low socio-economic status. 
Although Medicaid coverage is be associated with increased likelihood of misusing opioids, 
opioid misuse impacts women from all socio-economic backgrounds (Grol-Prokopcyzk, 
2018; Frenk et al., 2015). With this in mind, it will be important for future research to survey 
women from higher socio-economic backgrounds as well. In the current study, our sample 
was relatively homogeneous with regard to racial identity, with most of our participants 
identifying as Caucasian. Future research should aim to survey a diverse group of women to 
examine whether our findings generalize to other racial groups. We also unexpectedly found 
that age was a strong predictor of opioid misuse, such that women who are older are more 
likely to misuse opioids during pregnancy compared to women who are younger. It is 
possible that older women in our sample had dealt with such trauma for longer without 
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adequate psychotherapeutic intervention and thus were at an increased risk for opioid misuse. 
It is also possible that older women in our sample that experienced previous pregnancies 
which made the current pregnancy more stressful, thus increasing their risk for self-
medicating with opioids. Future research should examine factors which might increase risk 
for opioid misuse based on age.  
Implications of the current study are limited due to the cross-sectional design. For 
instance, measuring perceived stress before, during and after pregnancy and duration and 
severity of opioid misuse during, before, and after pregnancy would allow us to better 
understand the timeline of their symptoms. It is possible that women abusing opioids were 
more stressed during pregnancy due to the potential harm their drug use might be causing 
their baby in utero and not because they were more stressed prior to beginning to use opioids. 
Likewise, it is also possible that some women began using opioid before their pregnancy 
began and some began using opioids while pregnant. It will be important in future research to 
distinguish any differences between these two groups.  
Conclusion 
Opioid misuse creates unique challenges for pregnant women, their providers, and 
their unborn offspring. Women who experienced sexual abuse as children are more likely to 
avoid gynecological procedures. Furthermore, despite women reporting they prefer 
physicians to ask about trauma history, most physicians feel ill-prepared to inquire about a 
patient’s ACEs during medical appointments and many feel it is beyond the scope of their 
job. Adequately screening pregnant women for childhood sexual abuse history as a part of 
their prenatal care may help alert medical providers as to which women could be at an 
elevated risk for opioid misuse based on their history of sexual abuse. Given that sexual 
abuse history substantially increases the likelihood of opioid misuse in pregnancy, it is 
crucial for medical providers to integrate trauma-informed care into normal gynecology 
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practice. Doing so will encourage women with histories of sexual abuse to seek out medical 
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Table 1. Demographics and Gestation Differences between Opioid and High-Risk Medical 





(n = 55) 
Comparison 
 (n = 38) 
Opioid vs. 
Comparison 
 Variable M (SD)  M(SD)  M(SD)  t 
Age 27.2 (4.3)   28.2 (4.4) 25.7 (3.6) 2.94* 
Gestation 26.8 (7.9) 27.6 (7.9) 25.7 (7.9) 1.08 
% % %  χ2 
Minority Ethnic Background 16 7 29 7.81* 
Employed 17 15 21 0.69 
Has Partner 38 36 39 0.09 
Medicaid 100 100 100 0.00 
*p < .05
42 
Table 2. Presence of Maltreatment and Opioid Misuse 
B S.E. Wald df Sig. Exp(B) 
 Physical abuse .19 .54 .12 1 .73 1.21 
Neglect .22 .28 .60 1 .44 1.24 
Sexual abuse 1.16 .53 4.75 1  .03* 3.17 
Emotional abuse .10 .28 .13 1 .72 1.10 
*p < .05
43 
Table 3. Severity of Maltreatment and Opioid Misuse 
B S.E. Wald df Sig. Exp(B) 
 Physical abuse .03 .07 .12 1 .73 1.03 
Emotional abuse .03 .04 .61 1 .44 1.21 
Sexual abuse .19 .10 3.42 1   .06 1.21 
Neglect .04 .06 .38 1 .38 1.04 
*p < .05
44 
Table 4. Presence of Sexual Abuse versus Other Maltreatment Subtypes 
B S.E. Wald df Sig. Exp(B) 
 Minority status -1.27 .67 3.5 1   .06 .28 
Age .14 .06 5.10 1 .02* 1.15 
Physical abuse .08 .61 .02 1   .90 1.09 
Neglect .07 .38 .04 1  .85 1.08 
Emotional abuse -.23 .39 .33 1  .56 .80 
Sexual abuse 1.25 .59 4.44 1 .04* 3.50 
Constant -3.37 1.69 3.99 1   .05* .03 
*p < .05
45 
Table 5. Severity of Sexual Abuse versus Other Maltreatment Subtypes 
B S.E. Wald df Sig. Exp(B) 
 Minority status -1.25 .67 3.49 1 .06 .29 
Age .13 .06 5.06 1  .02* 1.15 
Physical abuse -.09 .12 .61 1 .43 .91 
Neglect .02 .07 .10 1 .74 1.02 
Emotional abuse -.02 .08 .07 1 .79 .98 
Sexual abuse .24 .13 3.31 1 .07 1.27 
Constant -3.16 1.62 3.80 1 .05 .04 
*p < .05
46 
Table 6. Sexual Abuse, Perceived Stress, and Opioid Misuse 
B S.E. Wald df Sig. Exp(B) 
 Minority status -1.18 .71 2.76 1   .10 .309 
Age .16 .07 6.45 1  .01* 1.178 
Perceived stress .05 .03 2.85 1  .09 1.049 
Sexual abuse -.50 1.33 .14 1  .71 .605 
Perceived stress X sexual abuse .08 .07 1.26 1  .26 1.085 
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